These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31534084)

  • 1. Generation Gap for Screening and Treatment of Hepatitis C Virus in Saga Prefecture, Japan: An Administrative Database Study of 35,625 Subjects.
    Isoda H; Oeda S; Takamori A; Sato K; Okada M; Iwane S; Takahashi H; Anzai K; Eguchi Y; Fujimoto K
    Intern Med; 2020 Jan; 59(2):169-174. PubMed ID: 31534084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct-acting antiviral treatment for hepatitis C virus infection and risk of incident liver cancer: a retrospective cohort study.
    Singer AW; Reddy KR; Telep LE; Osinusi AO; Brainard DM; Buti M; Chokkalingam AP
    Aliment Pharmacol Ther; 2018 May; 47(9):1278-1287. PubMed ID: 29516535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment access is only the first step to hepatitis C elimination: experience of universal anti-viral treatment access in Australia.
    Doyle JS; Scott N; Sacks-Davis R; Pedrana AE; Thompson AJ; Hellard ME;
    Aliment Pharmacol Ther; 2019 May; 49(9):1223-1229. PubMed ID: 30908706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C care cascade before and during the direct-acting antiviral eras in New South Wales, Australia: A population-based linkage study.
    Yousafzai MT; Alavi M; Valerio H; Hajarizadeh B; Grebely J; Dore GJ
    J Viral Hepat; 2023 Mar; 30(3):250-261. PubMed ID: 36537024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up.
    Litzroth A; Suin V; Wyndham-Thomas C; Quoilin S; Muyldermans G; Vanwolleghem T; Kabamba-Mukadi B; Verburgh V; Jacques M; Van Gucht S; Hutse V
    BMC Public Health; 2019 Jan; 19(1):39. PubMed ID: 30621662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness and health-related outcomes of screening for hepatitis C in Korean population.
    Kim KA; Chung W; Choi HY; Ki M; Jang ES; Jeong SH
    Liver Int; 2019 Jan; 39(1):60-69. PubMed ID: 29998565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review: economic evaluations of HCV screening in the direct-acting antivirals era.
    Cortesi PA; Barca R; Giudicatti G; Mossini S; Ciaccio A; Iannazzo S; Micale M; Cesana G; Mantovani LG
    Aliment Pharmacol Ther; 2019 May; 49(9):1126-1133. PubMed ID: 30843268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timely Hepatitis C RNA Testing and Treatment in the Era of Direct-Acting Antiviral Therapy among People with Hepatitis C in New South Wales, Australia.
    Yousafzai MT; Alavi M; Valerio H; Hajarizadeh B; Grebely J; Dore GJ
    Viruses; 2022 Jul; 14(7):. PubMed ID: 35891474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver Disease Screening and Hepatitis C Virus Elimination in Taiwan Rural Indigenous Townships: Village-By-Village Screening and Linking to Outreach Hepatology Care.
    Tien HM; Cheng TC; Lien HC; Yang KF; Shy CG; Chen YL; Hsu NT; Lu SN; Wang JH
    Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35328957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Alcohol Use Disorder and Receipt of Direct-Acting Antiviral Hepatitis C Virus Treatment.
    Haque LY; Fiellin DA; Tate JP; Esserman D; Bhattacharya D; Butt AA; Crystal S; Edelman EJ; Gordon AJ; Lim JK; Tetrault JM; Williams EC; Bryant K; Cartwright EJ; Rentsch CT; Justice AC; Lo Re V; McGinnis KA
    JAMA Netw Open; 2022 Dec; 5(12):e2246604. PubMed ID: 36515952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change in treatment paradigm in people who previously injected drugs with chronic hepatitis C in the era of direct-acting antiviral therapy.
    Wong GL; Chan HL; Loo CK; Hui YT; Fung JY; Cheung D; Chung C; Chim AM; Wong VW;
    J Gastroenterol Hepatol; 2019 Sep; 34(9):1641-1647. PubMed ID: 30707777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake of direct-acting antiviral treatment for chronic hepatitis C in Australia.
    Hajarizadeh B; Grebely J; Matthews GV; Martinello M; Dore GJ
    J Viral Hepat; 2018 Jun; 25(6):640-648. PubMed ID: 29274192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micro-elimination of hepatitis C virus infection in the rural and remote areas of Taiwan - A multi-center collaborative care model.
    Lo CC; Lei WY; Huang YC; Hwang JJ; Lo CY; Lin CH; Cheng HS; Liao YT; Liang PC; Chiou MJ; Bair MJ; Dai CY; Yu ML
    J Microbiol Immunol Infect; 2023 Aug; 56(4):680-687. PubMed ID: 36822945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis.
    Comarmond C; Garrido M; Pol S; Desbois AC; Costopoulos M; Le Garff-Tavernier M; Si Ahmed SN; Alric L; Fontaine H; Bellier B; Maciejewski A; Rosenzwajg M; Klatzmann D; Musset L; Poynard T; Cacoub P; Saadoun D
    Gastroenterology; 2017 Jun; 152(8):2052-2062.e2. PubMed ID: 28274850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C Treatment Initiation Among US Medicaid Enrollees.
    Kapadia SN; Zhang H; Gonzalez CJ; Sen B; Franco R; Hutchings K; Wethington E; Talal A; Lloyd A; Dharia A; Wells M; Bao Y; Shapiro MF
    JAMA Netw Open; 2023 Aug; 6(8):e2327326. PubMed ID: 37540513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current elimination status of hepatitis C virus-infected maintenance hemodialysis patients in Iwate Prefecture, Japan.
    Miyasaka A; Yoshida Y; Suzuki A; Endo K; Kakisaka K; Oikawa T; Abe T; Obara W; Matsumoto T
    Ther Apher Dial; 2023 Oct; 27(5):848-854. PubMed ID: 37125473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global cascade of care for chronic hepatitis C virus infection: A systematic review and meta-analysis.
    Yousafzai MT; Bajis S; Alavi M; Grebely J; Dore GJ; Hajarizadeh B
    J Viral Hepat; 2021 Oct; 28(10):1340-1354. PubMed ID: 34310812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating hepatitis C cascade of care surveillance system in Tuscany, Italy, through a population retrospective data-linkage study, 2015-2021.
    Ceccarelli L; Moretti G; Mazzilli S; Petri D; Corazza I; Rizzo C; Lucenteforte E; Vainieri M; Seghieri C; Tavoschi L;
    BMC Infect Dis; 2024 Mar; 24(1):362. PubMed ID: 38553731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Elimination of hepatitis C virus in Denmark].
    Døssing A; Røge BT; Madsen LG; Laursen AL; Hansen JB; Bukh J; Weis N
    Ugeskr Laeger; 2020 Feb; 182(9):. PubMed ID: 32138816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collaborative Referral Model for Hepatitis C Screening and Treatment in a Remote Mountainous Region of Taiwan during the COVID-19 Pandemic.
    Tai CM; Bair MJ; Chen TH; Tseng CH; Chen CC; Lam H; Yu ML
    Viruses; 2023 Mar; 15(4):. PubMed ID: 37112808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.